The DOI matches its Crossref record.
Effects of Free Fatty Acids (FFA) on Glucose Metabolism: Significance for Insulin Resistance and Type 2 Diabetes
Abstract
Most obese individuals have elevated plasma levels of free fatty acids (FFA) which are known to cause peripheral (muscle) insulin resistance. They do this by inhibiting insulin-stimulated glucose uptake and glycogen synthesis. The mechanism involves intramyocellular accumulation of diacylglycerol and activation of protein kinase C. FFAs also cause hepatic insulin resistance. They do this by inhibiting insulin-mediated suppression of glycogenolysis. On the other hand, FFAs support between 30 and 50 % of basal insulin secretion and potentiate glucose-stimulated insulin secretion. The insulin stimulatory action of FFAs is responsible for the fact that the vast majority ( approximately 80 %) of obese insulin resistant people do not develop type 2 diabetes. They are able to compensate for their FFA mediated insulin resistance with increased FFA mediated insulin secretion. Individuals who are unable to do this (probably for genetic reasons) eventually develop type 2 diabetes. FFAs have recently been shown to activate the IkappaB/NFkappaB pathway which is involved in many inflammatory processes. Thus, elevated plasma levels of FFAs are not only a major cause of insulin resistance in skeletal muscle and liver but may, in addition, play a role in the pathogenesis of coronary artery disease.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Obesity-related type 2 diabetes patients often have elevated plasma FFAs, because of either increased amounts of FFAs released from large amounts of adipose tissue or impaired FFA clearance [258].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [258]
In the citing paper
“Alterations in non-esterified (i.e. free) fatty acid (NEFA) levels play a central role in the pathogenesis of insulin resistance and the development of metabolic diseases [8, 9].”
From Sleep restriction increases free fatty acids in healthy men (2015) · cites this paper as [9]
Citations
Cited by
Sorted by citations
Items 101–200 of 341
Glucagon as a Critical Factor in the Pathology of Diabetes
Edgerton, D. S., & Cherrington, A. D. (2011) · Diabetes · doi:10.2337/db10-1594 · Cited by 47
“In any event, NEFAs have been shown to inhibit hepatic and muscle glucose uptake (30).”
BackgroundLipotoxic Impairment of Mitochondrial Function in β-Cells: A Review
Römer, A., Linn, T., & Petry, S. F. (2021) · Antioxidants · doi:10.3390/antiox10020293 · Cited by 52
“By those factors, it plays a central role in β-cell decay and development of T2DM.”
BackgroundInfluentialThe cat as a model for human nutrition and disease
Hoenig, M. E. (2006) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/01.mco.0000241668.30761.69 · Cited by 45
Bouderba, S., Sànchez‐Martìn, C., Villanueva, G. R., Détaille, D., & Koceir, E.-A. (2013) · Journal of Diabetes · doi:10.1111/1753-0407.12083 · Cited by 46
“Also, there exists convincing evidence that insulin resistance was linked to an increased production of fatty acids that impaired blood lipids in either insulin-resistant or diabetic subjects.(26) This harmful pattern was encountered in diabetic P.”
BackgroundContribution of Adipose Tissue to Health Span and Longevity
Huffman, D. M., & Barzilai, N. (2010) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000319991 · Cited by 45
Martikainen, T., Teppo, A., Grönhagen‐Riska, C., et al. (2005) · Blood Purification · doi:10.1159/000086553 · Cited by 45
Mechanisms for early microvascular injury in obesity and type II diabetes
Bohlen, H. G. (2004) · Current Hypertension Reports · doi:10.1007/s11906-004-0013-9 · Cited by 45
Varani, K., Vincenzi, F., Merighi, S., Gessi, S., & Borea, P. A. (2017) · Advances in experimental medicine and biology · doi:10.1007/5584_2017_61 · Cited by 43
Shetty, S. S., Kumari, S., & Shetty, P. K. (2020) · Nutrition · doi:10.1016/j.nut.2020.110968 · Cited by 43
Alkhateeb, H. H., & Bonen, A. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00216.2010 · Cited by 43
High-fat and obesogenic diets: current and future strategies to fight obesity and diabetes
Teodoro, J. S., Varela, A. T. I. F., Rolo, A. P., & Palmeira, C. M. (2014) · Genes & Nutrition · doi:10.1007/s12263-014-0406-6 · Cited by 45
Kiilerich, K., Gudmundsson, M., Birk, J. B., Lundby, C., Taudorf, S., Plomgaard, P., Saltin, B., Pedersen, P. A., Wojtaszewski, J. F. P., & Pilegaard, H. (2009) · Diabetes · doi:10.2337/db09-1032 · Cited by 42
“Thus, although there was no effect of elevated FFA on PDHa activity at rest in the present study, maybe due to the overnight high-fat diet in both trials, elevated FFA levels have been shown to induce insulin resistance (31,32), and individuals with enhanced circulating FFA levels like type 2 diabetic subjects may exp…”
BackgroundRapamycin and Dietary Restriction Induce Metabolically Distinctive Changes in Mouse Liver
Yu, Z., Wang, R., Fok, W. C., Coles, A., Salmon, A. B., & Pérez, V. (2014) · The Journals of Gerontology Series A · doi:10.1093/gerona/glu053 · Cited by 41
“are typically associated with impaired insulin-mediated glucose uptake (36), and acute elevation in plasma-free fatty acid concentrations for 5 hours induced insulin resistance in a rat model, as reflected by a ~35% reduction in the glucose infusion rate during an hyperinsulinemic–euglycemic clamp (37).”
BackgroundXin, Y., Wang, Y., Chi, J., Zhu, X., Zhao, H., Zhao, S., & Wang, Y. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s186505 · Cited by 40
“A study had further shown that abundant FFAs lead to increased phosphorylation of serine/threonine on insulin receptors and insulin receptor substrate (IRS)-1, thereby activating the signaling inhibition function of protein kinase C.(10) Through downregulation of IkB-α, FFAs indirectly activate NF-kβ signaling, which…”
BackgroundInfluentialEffects of T2DM on cancer progression: pivotal precipitating factors and underlying mechanisms
Zhang, Y., Li, Y., Xue, C., Li, S., Gao, Z., & Qin, K. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1396022 · Cited by 45
Treating hyperuricemia related non-alcoholic fatty liver disease in rats with resveratrol
Xu, K., Liu, S., Zhao, X. D., Zhang, X., Fu, X., Zhou, Y., Xu, K., Miao, L., Li, Z., Li, Y., et al. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.12.039 · Cited by 38
Rosiglitazone Prevents Free Fatty Acid-Induced Vascular Endothelial Dysfunction
Mittermayer, F., Schaller, G., Pleiner, J., Krzyżanowska, K., Kapiotis, S., Roden, M., & Wolzt, M. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2130 · Cited by 38
Progress of potential drugs targeted in lipid metabolism research
Liang, K., & Dai, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1067652 · Cited by 37
“In obese patients, elevated triglyceride levels lead to increased levels of free fatty acids, which can lead to insulin resistance and glucose intolerance (Boden, 2003).”
BackgroundMahdavi, A., Moradi, S., Askari, G., Iraj, B., Sathyapalan, T., Guest, P. C., Bagherniya, M., & Sahebkar, A. (2021) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-56153-6_8 · Cited by 35
Leone, A., Martínez‐González, M. Á., Craig, W. J., Fresán, U., Gómez‐Donoso, C., & Bes‐Rastrollo, M. (2021) · Nutrients · doi:10.3390/nu13072202 · Cited by 44
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.01.042 · Cited by 35
“Metformin, acting via AMPK, can also promote fat oxidation in other tissues – including skeletal muscle, liver, and b cells – in which “lipotoxicity” contributes importantly to the physiological malfunctions that characterize insulin resistance syndrome and type 2 diabetes [16,54–58].”
BackgroundType 2 Diabetes: An Expanded View of Pathophysiology and Therapy
Unger, J., & Parkin, C. G. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.05.2152 · Cited by 36
Constantinopoulos, P., Michalaki, M. A., Kottorou, A. E., Habeos, I. G., Psyrogiannis, A. I., Kalfarentzos, F., & Kyriazopoulou, V. E. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0626 · Cited by 35
Gluconeogenesis and risk for fasting hyperglycemia in Black and White women.
Chung, S., Courville, A., Onuzuruike, A. U., Galvan-Delacruz, M., Mabundo, L. S., Dubose, C. W., Kasturi, K., Cai, H.-Y., Gharib, A., Walter, P. J., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121495 · Cited by 35
Qi, Y., Du, X., Yao, X., & Zhao, Y. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1578783 · Cited by 34
“Obesity-related type 2 diabetes patients often have elevated plasma FFAs either because an increased amount of FFAs is released from their large amounts of adipose tissue or they have an impaired FFA clearance mechanism [4].”
BackgroundChen, W., Wang, L., Liu, H., Long, L., & Li, S. (2008) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2008.00268.x · Cited by 35
Francaux, M. (2009) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h09-036 · Cited by 33
“A number of experimental evidence indicate that NEFAs play a role in the etiology of the associated insulin resistance (Boden 2003) and point out the role of proinflammatory signalling networks.”
BackgroundLi, J., Yuan, Y., Zhang, W., et al. (2018) · Journal of Pharmacy and Pharmacology · doi:10.1111/jphp.13023 · Cited by 32
“In addition, FFAs also interfere with the combination of insulin and its receptor, resulting in secretion of a series of cell secretory factors, thereby promoting insulin resistance.([24]) In accordance with our results, the elevated levels of plasma TC, TG, LDL-C, FFA were decreased after treated with RIP for 4 weeks…”
ResultXu, K., Zhao, X. D., Fu, X., Xu, K., Li, Z., Miao, L., Li, Y., Cai, Z., Qiao, L., & Bao, J. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109158 · Cited by 33
McCarty, M. F. (2004) · Medical Hypotheses · doi:10.1016/j.mehy.2004.03.034 · Cited by 32
Tian, J., Feng, B., & Tian, Z. (2022) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2022/8278744 · Cited by 31
“On the other hand, dyslipidemia-induced fat deposition could aggravate the dysfunction of pancreatic beta cells and inhibit insulinstimulated glucose uptake and glycogen synthesis in diabetes [40,41].”
BackgroundMalin, S. K., Kashyap, S., Hammel, J. P., Miyazaki, Y., DeFronzo, R. A., & Kirwan, J. P. (2014) · Diabetes Care · doi:10.2337/dc13-3011 · Cited by 31
“plasma FFA by insulin plays an important role in not only the development of insulin resistance (8,14,24) but also b-cell dysfunction (9,10).”
BackgroundFriedrichsen, M. H., Poulsen, P., Wojtaszewski, J. F. P., Hansen, P. R., Vaag, A. A., & Rasmussen, H. B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056861 · Cited by 33
“Notably, increased CES1-mediated lipolysis in adipose tissue could cause disturbances of the glucose metabolism by elevation of the plasma levels of non-esterified fatty acids that can induce muscle and hepatic insulin resistance [30,31] Also, cholesterol imbalance in adipocytes seems capable of inducing insulin resis…”
BackgroundKim, M., Song, K., & Kim, Y. S. (2017) · International Immunopharmacology · doi:10.1016/j.intimp.2017.05.037 · Cited by 30
Salau, V. F., Erukainure, O. L., Ijomone, O. M., & Islam, M. S. (2022) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgac021 · Cited by 31
Influence of Large-Volume Liposuction on Metabolic and Cardiovascular Health
Sailon, A. M., Wasserburg, J. R., Kling, R. R., Pasick, C. M., & Taub, P. J. (2017) · Annals of Plastic Surgery · doi:10.1097/sap.0000000000001195 · Cited by 30
“Subcutaneous adipose tissue is the principal storage organ for triglycerides and is therefore critical to both cholesterol metabolism and lipid profile balance.(6) When energy intake is surplus, excess triglycerides are stored through uptake of fatty acids from circulating very low density lipoproteins or synthesized…”
BackgroundZhang, L., Wu, Y., Jia, Z., Zhang, Y., Shen, Y. H., & Wang, X. L. (2008) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-8-39 · Cited by 27
Liu, M., Wang, L., Li, X., Wu, Y., Yin, F., & Liu, J. (2020) · Chinese Medicine · doi:10.1186/s13020-020-00390-2 · Cited by 36
Perspectives from metabolomics in the early diagnosis and prognosis of gestational diabetes mellitus
Zhang, M., & Yang, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.967191 · Cited by 28
Cardiovascular risk assessment in metabolic syndrome: view from PROCAM
Assmann, G., Nofer, J., & Schulte, H. (2004) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2004.03.017 · Cited by 29
“Actually, FFAs were postulated to impair the function of insulin receptor and contribute to insulin resistance in striated muscles [24].”
BackgroundSabatini, S., Sen, P., Carli, F., Pezzica, S., Rosso, C., Lembo, E., Verrastro, O., Daly, A. K., Govaere, O., Cockell, S., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101820 · Cited by 32
Overview of Transcriptomic Research on Type 2 Diabetes: Challenges and Perspectives
Tonyan, Z. N., Nasykhova, Y. A., Danilova, M. M., Barbitoff, Y. A., Changalidis, A. I., Mikhailova, A. A., & Glotov, A. S. (2022) · Genes · doi:10.3390/genes13071176 · Cited by 26
“Plasma free fatty acids are known as one of the causes of peripheral insulin resistance [72].”
BackgroundWang, C., Li, X., Zhang, W., Liu, W., Lv, Z., Gui, R., Li, M., Li, Y., Sun, X., Liu, P., et al. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.02.017 · Cited by 27
Current Perspectives: Obesity and Neurodegeneration - Links and Risks
Kueck, P. J., Morris, J. K., & Stanford, J. A. (2024) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s388579 · Cited by 30
“50 Hyperglycemia stimulates the glycolytic pathway and the Krebs cycle, leading to a heightened influx of electron carriers into the mitochondria.”
BackgroundKomosińska‐Vassev, K., Olczyk, K., Koźma, E. M., Olczyk, P., Wisowski, G., & Winsz‐Szczotka, K. (2005) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm.2005.158 · Cited by 25
Zhang, Y., Wan, J., Xu, Z., Hua, T., & Sun, Q. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27508 · Cited by 25
“…1; TRAF3: tumor necrosis factor receptor‐ associated factor 3 [Color figure can be viewed at wileyonlinelibrary.com] All these consequences provided potent proof for the abnormal glucose and lipid metabolism as the crucial pathogenetic event for IR (Boden, 2001, 2003; Wolf, 2008; Yu et al., 2016).”
BackgroundSalau, V. F., Erukainure, O. L., Olofinsan, K. A., Msomi, N. Z., Ijomone, O. M., & Islam, M. S. (2021) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2021.1988981 · Cited by 26
“Persistent hyperglycaemia and excessive systemic free fatty acid are major players in the inhibition of insulin-stimulated glucose uptake and glycogenesis as well as development of OS in T2D (Boden 2003).”
BackgroundXin, W., Zhao, X., Liu, L., Xu, Y., Li, Z., Chen, L., Wang, X., Yi, F., & Wan, Q. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.05.070 · Cited by 26
Vijay‐Kumar, M., Aitken, J. D., Carvalho, F. A., Ziegler, T. R., Gewirtz, A. T., & Ganji, V. (2011) · Journal of Inflammation · doi:10.1186/1476-9255-8-2 · Cited by 25
“These elevated FFAs interfere with insulin function (unable to suppress hepatic glucose production and stimulate glucose influx into muscle and adipocytes) leading to insulin resistance [26-29].”
BackgroundPolysaccharide-Enriched Fraction from Amillariella Mellea Fruiting Body Improves Insulin Resistance
Yang, S., Meng, Y., Yan, J., Wang, N., Xue, Z., Zhang, H., & Fan, Y. (2018) · Molecules · doi:10.3390/molecules24010046 · Cited by 25
“Accumulating studies suggest the relationship between lipid oversupply and insulin resistance [3,4].”
BackgroundRole of the Gut Microbiome in Beta Cell and Adipose Tissue Crosstalk: A Review
Martínez‐Montoro, J. I., Damas-Fuentes, M., Fernández‐García, J. C., & Tinahones, F. J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.869951 · Cited by 28
Lee, C.-H., Chiang, C.-F., Lin, F., Kuo, F.-C., Su, S., Huang, C., Li, P., Liu, J., Lu, C., Hsieh, C., et al. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1053882 · Cited by 25
Meissner, M., Herrema, H., van Dijk, T. H., Gerding, A., Havinga, R., Boer, T. S., Müller, M. M., Reijngoud, D., Groen, A. K., & Kuipers, F. (2011) · PLoS ONE · doi:10.1371/journal.pone.0024564 · Cited by 24
“, the switch to glucose oxidation cannot be made and insulin is unable to stimulate glucose oxidation [44].”
BackgroundHetta, M. H., Owis, A. I., Haddad, P. S., et al. (2017) · Pharmaceutical Biology · doi:10.1080/13880209.2017.1280687 · Cited by 24
“Care was also taken to identify the kind of fatty acids present in our non-polar extracts since saturated fatty acids have generally been suspected to be detrimental to health and to worsen diabetic situations (Boden & Shulman 2002; Boden 2003), albeit this is a matter of continuing debate (discussed further below).”
BackgroundTherapeutic Applications of Type 2 Diabetes Mellitus Drug Metformin in Patients with Osteoarthritis
Song, P., Hwang, J. S., Park, H. C., Kim, K. K., Son, H., Kim, Y., & Lee, K. M. (2021) · Pharmaceuticals · doi:10.3390/ph14020152 · Cited by 25
“FFAs also cause hepatic insulin resistance by inhibiting insulin-mediated suppression of glycogenolysis [47].”
BackgroundEffects of Hydroxy-Alpha-Sanshool on Intestinal Metabolism in Insulin-Resistant Mice
Xu, F., Zhu, Y., Lu, M., Qin, L., Zhao, D., & Ren, T. (2022) · Foods · doi:10.3390/foods11142040 · Cited by 22
“Some studies have established that the tyrosine metabolic pathway is closely associated with IR and has varying degrees of impact on fasting and postprandial blood glucose [43].”
BackgroundMurthy, S. N. P., Chung, P. H., Li, L., & Lomasney, J. W. (2006) · Biochemistry · doi:10.1021/bi060648+ · Cited by 22
Gallis, J., Tissier, P., Gin, H., et al. (2007) · BMC Physiology · doi:10.1186/1472-6793-7-8 · Cited by 21
Son, J. W., Jang, E.-H., Kim, M., Baek, K., Song, K., Yoon, K., Cha, B., Son, H., Lee, K., Jo, H., et al. (2011) · Biomarkers in Medicine · doi:10.2217/bmm.11.81 · Cited by 20
Zhang, X., Yang, Y., Lai, Z., Ji, S., Yu, G., Xie, Z., Zhang, H., Zhong, X., Wang, T., & Zhang, L. (2023) · Journal of Animal Science and Biotechnology/Journal of animal science and biotechnology · doi:10.1186/s40104-023-00828-1 · Cited by 23
Trinh, M. D., Plihalova, A., Gojda, J., Westlake, K., Spicka, J., Lattova, Z., Pretl, M., & Polak, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-83018-1 · Cited by 20
Broussard, J. L., Kolka, C. M., Castro, A. V., Bediako, I. A., Paszkiewicz, R. L., Szczepaniak, E. W., Szczepaniak, L. S., Knutson, K. L., Kim, S. P., & Bergman, R. N. (2015) · Diabetologia · doi:10.1007/s00125-015-3721-6 · Cited by 20
“During obesity, excessive NEFAmay be a major cause of beta cell dysfunction [37–41].”
BackgroundAguerd, O., Elhrech, H., Fessikh, M. E., Goh, K. W., Omari, N. E., Aanniz, T., & Bouyahya, A. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106705 · Cited by 24
Pereira, M. J., Vranic, M., Kamble, P. G., Jernow, H., Kristófi, R., Holbikova, E., Skrtic, S., Kullberg, J., Svensson, M. K. E., Hetty, S., et al. (2021) · Translational research · doi:10.1016/j.trsl.2021.12.003 · Cited by 20
Lee, B., Kim, S. Y., Cho, B. W., Suh, S., Park, K. K., & Choi, Y. S. (2022) · World Journal of Surgery · doi:10.1007/s00268-021-06437-1 · Cited by 21
“Although FFAs are important energy sources, particularly during fasting, abnormalities in FFA metabolism may contribute to the pathogenesis of atherosclerosis and cardiovascular diseases in patients with type 2 diabetes [32, 33].”
BackgroundZhou, J., Shi, Y., Yang, C., Lü, S., Zhao, L., Liu, X., Zhou, D., Luo, L., & Yin, Z. (2023) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2023.109404 · Cited by 23
Breed difference and regulation of the porcine Sirtuin 1 by insulin1
Shan, T., Ren, Y., Liu, Y., Zhu, L., & Wang, Y. (2010) · Journal of Animal Science · doi:10.2527/jas.2010-2880 · Cited by 19
“Insulin, a major regulator of lipolysis, has a vital role in regulating glucose uptake, lipid metabolism, preadipocyte differentiation, and lipogenesis (Boden, 2003).”
BackgroundHuang, J., Qin, S., Huang, L., Tang, Y., Ren, H., & Hu, H. (2019) · Journal of Human Nutrition and Dietetics · doi:10.1111/jhn.12648 · Cited by 20
Sex-Associated Differences in Free Fatty Acid Flux of Obese Adolescents
Adler‐Wailes, D. C., Periwal, V., Ali, A. H., Brady, S. M., McDuffie, J. R., Uwaifo, G. I., Tanofsky‐Kraff, M., Salaita, C. G., Hubbard, V. S., Reynolds, J. C., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3817 · Cited by 19
Burghardt, K. J., Gardner, K. N., Johnson, J. W., & Ellingrod, V. L. (2013) · Cardiovascular Psychiatry and Neurology · doi:10.1155/2013/596945 · Cited by 18
Zhang, Y., Wan, J., Liu, S., Hua, T., & Sun, Q. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.05.040 · Cited by 18
Exercise ameliorates insulin resistance and improves ASK1‐mediated insulin signalling in obese rats
Zhang, Y., Ye, T., Zhou, P., Li, R., Liu, Z., Xie, J., Hua, T., & Sun, Q. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16994 · Cited by 18
Effect of APOE ε4 Genotype on Metabolic Biomarkers in Aging and Alzheimer’s Disease
Morris, J. K., Uy, R. A. Z., Vidoni, E. D., Wilkins, H., Archer, A. E., Thyfault, J. P., Miles, J. M., & Burns, J. M. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170148 · Cited by 20
Yang, Y., Chen, M., Loux, T., & Harmon, C. M. (2007) · Pediatric Surgery International · doi:10.1007/s00383-007-1942-6 · Cited by 17
“Thus, catecholamines are strong activators of lipolysis leading to increased serum levels of FFA in obese patients and high levels of FFA results in insulin resistance in various tissues including muscle, liver, and fat [32, 45].”
BackgroundDyslipidemia in insulin resistance: clinical challenges and adipocentric therapeutic frontiers
Toh, S.-A. E. S., & Rader, D. J. (2008) · Expert Review of Cardiovascular Therapy · doi:10.1586/14779072.6.7.1007 · Cited by 17
Nemati, R., Lu, J., Tura, A., Smith, G., & Murphy, R. (2016) · Obesity Surgery · doi:10.1007/s11695-016-2323-9 · Cited by 17
Early pregnancy plasma fatty acid profiles of women later diagnosed with gestational diabetes
Tryggvadottir, E. A., Gunnarsdottir, I., Birgisdottir, B. E., Hrolfsdottir, L., Landberg, R., Hreidarsdottir, I. T., Hardardottir, H., & Halldorsson, T. I. (2021) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2021-002326 · Cited by 16
Barrett, J. S., Whytock, K. L., Strauss, J. A., Wagenmakers, A. J. M., & Shepherd, S. O. (2022) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2021-0631 · Cited by 17
Johnson, J. D. (2009) · Cell Cycle · doi:10.4161/cc.8.1.7343 · Cited by 16
Associations Between Serum Free Fatty Acid Levels and Incident Diabetes in a 3-Year Cohort Study
Li, Q., Zhao, M., Wang, Y., Zhong, F., Liu, J., Gao, L., & Zhao, J. (2021) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s302681 · Cited by 16
“uptake, oxidation, and glycogen synthesis in liver and skeletal muscle.(14,15,24,25) The deleterious effects of chronically”
BackgroundHuang, C., Chen, D., Tian, G., He, J., Zheng, P., Yu, J., Mao, X., Huang, Z., Yan, H., Wang, Q., et al. (2021) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/jpn.13673 · Cited by 16
Das, G. C., & Hollinger, F. B. (2012) · Virology · doi:10.1016/j.virol.2012.07.003 · Cited by 16
Subramanian, R., Asmawi, M. Z., & Sadikun, A. (2008) · Pharmaceutical Biology · doi:10.1080/13880200802316079 · Cited by 16
“Free fatty acids (FFA) have also been implicated in the development of T2DM (Boden, 2003) by causing a decreased peripheral glucose utilization leading to insulin resistance.”
BackgroundHeiston, E. M., & Malin, S. K. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12668-1_15 · Cited by 17
Gong, L., Jin, H., Li, Y., Quan, Y., Yang, J., Tang, Q., & Zou, Z. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.09.144 · Cited by 15
Kim, S.-W., Jung, W., Chung, S., & Park, H. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i4.331 · Cited by 16
Bao, S., Wang, X., Cho, S. B., Wu, Y., Wei, C., Han, S., Bao, L., Wu, Q., Ao, W., & Nan, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.656220 · Cited by 17
“Moreover, many animal and human studies have demonstrated that FFAs are key factors responsible for IR (Boden 2003; Makarova et al., 2019; Qureshi et al., 2019).”
BackgroundCystic fibrosis related liver disease and endocrine considerations
Sherwood, J. S., Ullal, J., KUTNEY, K. A., & Hughan, K. S. (2021) · Journal of Clinical & Translational Endocrinology · doi:10.1016/j.jcte.2021.100283 · Cited by 14
“Furthermore, insulin resistance is associated with elevated levels of free fatty acids which can cause peripheral insulin resistance by inhibiting insulin-stimulated glucose uptake and glycogen synthesis, further contributing to impaired glucose utilization [70].”
Background[THE FATTY ACIDS AND RELATIONSHIP WITH HEALTH].
Catalán, J. S., Durán‐Agüero, S., & Torres, J. (2015) · PubMed · doi:10.3305/nh.2015.32.3.9276 · Cited by 24
Gao, S.-H., Zhao, D., Bai, Y., Wu, R., Mo, F., Liu, C., Zhu, R., Jiang, G., Liu, J.-X., & Zhang, D. (2019) · World Journal of Traditional Chinese Medicine · doi:10.4103/wjtcm.wjtcm_3_19 · Cited by 14
“The elevation of plasma FFA is a clinical feature of T2DM and obesity, and plays a decisive role in leading to IR.”
ResultInfluentialPreprocessing Factors Affected Free Fatty Acid Content in Crude Palm Oil Quality
Edyson, E., Murgianto, F., Ardiyanto, A., et al. (2022) · Jurnal Ilmu Pertanian Indonesia · doi:10.18343/jipi.27.2.177 · Cited by 14
“Consuming food with high levels of free fatty acid will increase the level of low-density lipoprotein (LDL), lower the level of high-density lipoprotein (HDL) of blood, and reduce the response to the hormone insulin (Boden 2003).”
BackgroundHinkley, J. M., Zou, K., Park, S., Zheng, D., Dohm, G. L., & Houmard, J. A. (2017) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2017.05.019 · Cited by 14
“[18] observed that 2 weeks following RYGB surgery, there was a significant increase in lipolysis resulting in an increase in plasma free fatty acids, which may have masked muscle-specific changes in the acute period after the intervention, as a rise in plasma free fatty acids has been shown to induce insulin resistanc…”
BackgroundSater, Z. A., Cero, C., Pierce, A. E., Lea, H. J., Sater, H. A., ZHU, K. Y., Liu, N., Ma, Y., Gavrilova, O., & Cypess, A. M. (2021) · Obesity · doi:10.1002/oby.23309 · Cited by 13
“Simultaneously, higher FFA may increase AT inflammation, insulin resistance, and nonalcoholic fatty liver disease (40).”
The role of key adipokines in obesity and insulin resistance in cats
Lusby, A. L., Kirk, C. A., & Bartges, J. W. (2009) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.235.5.518 · Cited by 13
“Lipid accumulation in cells can lead to lipotoxicosis, which has been implicated in the development of peripheral insulin resistance.(17,18) Administration of leptin decreases cellular lipid stores in pancreatic, adipose, hepatic, and cardiac tissues of rodents.”
BackgroundBrenner, M., Abadi, S. E. M., Balouchzadeh, R., Lee, H. F., Ko, H. S., Johns, M. S., Malik, N., Lee, J. J., & Kwon, G. (2017) · Heliyon · doi:10.1016/j.heliyon.2017.e00310 · Cited by 14
“The link between obesity and T2DM involves proinflammatory cytokines (tumor necrosis factor and interleukin-6), insulin resistance, glucolipotoxicity associated with nutrient overload, and alterations in cellular processes such as mitochondrial dysfuncton and endoplasmic reticulum stress [3, 4, 5, 6].”
BackgroundInsulin resistance in young, lean male subjects with essential hypertension
Penesová, A., Cizmárová, E., Belan, V., Blazicek, P., Imrich, R., Vlček, M., Vigas, M., Selko, D., Koška, J., & Rádiková, Ž. (2010) · Journal of Human Hypertension · doi:10.1038/jhh.2010.72 · Cited by 14
Tajiri, E., Yoshimura, E., Tobina, T., Yamashita, T., Kume, K., Hatamoto, Y., & Shimoda, S. (2023) · Appetite · doi:10.1016/j.appet.2023.106998 · Cited by 16
The growing use of continuous glucose monitors in people without diabetes: an evidence‐free zone
Guess, N. D. (2023) · Practical Diabetes · doi:10.1002/pdi.2475 · Cited by 16
Zhao, Q., Xu, H., Zhang, L., Liu, L., & Wang, L. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1620248 · Cited by 13
“population has elevated levels of plasma free fatty acid (FFA), which can interfere with insulin action in bone and muscle development, and cause peripheral insulin resistance [3].”
BackgroundRetractedAziz, A. A., Anderson, G. H., Giacca, A., & Cho, F. (2005) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00850.2004 · Cited by 12
“The higher plasma FFA concentrations found in rats receiving WP Ex-4 compared with those receiving WP only (Table 3) are consistent with the hyperglycemia because FFA enhance hepatic glucose production and inhibit glucose uptake (6, 22).”
Background
Metadata
- Authors
- Boden, G.
- Affiliations
- Temple University (US)
- Corresponding author
- Boden, G.
- Venue
- Experimental and Clinical Endocrinology & Diabetes
- Publisher
- Georg Thieme Verlag KG
- Published
- 2003-06-04
- Volume
- 111
- Issue
- 03
- Pages
- 121-124
- ISSN
- 0947-7349 (ISSN-L)
- 1439-3646
- OpenAlex
- W121967333
- Cited by
- 348
- References
- 0
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 20 · 2023: 17 · 2022: 26 · 2021: 30 · 2020: 17 · 2019: 17 · 2018: 15 · 2017: 16 · 2016: 9 · 2015: 12 · 2014: 14 · 2013: 13 · 2012: 18
- FWCI
- 14.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Experimental and Clinical Endocrinology & Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01ag007988-10, 5r01ag015363-05)
- National Institute on Aging (AG15363, R01-AG07988)
- National Center for Research Resources (2 M01-RR-349)
- NIH Clinical Center
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- free fatty acids, insulin resistance, type 2 diabetes, glucose metabolism, skeletal muscle insulin signaling, hepatic insulin resistance, insulin secretion, diacylglycerol, protein kinase C, glycogen synthesis, glycogenolysis, obesity, NF-κB signaling, inflammation, coronary artery disease
- MeSH terms
- Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Glucose, Humans, Insulin Resistance, Liver, Obesity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review